Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations

Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations

Recurrent vulvovaginal candidiasis (RVVC) is a relapsing vaginal fungal infection caused by <i>Candida</i> species. The prevalence varies among age populations and can be as high as 9%. Treatment options are limited, and in 57% of the cases, relapses occur within six months after flucona...

Full description

Bibliographic Details
Main Authors:	Senna J. J. M. van Riel, Celine M. J. G. Lardenoije, Guy J. Oudhuis, Niels A. J. Cremers
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Journal of Fungi
Subjects:	recurrent vulvovaginal candidiasis medical-grade honey fluconazole alternative treatment micro-environment modulation
Online Access:	https://www.mdpi.com/2309-608X/7/8/664

Similar Items

Epidemiological profile and fluconazole susceptibility of patients with vulvovaginal candidiasis in northeast Iran
by: Raheleh Alhashem, et al.
Published: (2024-01-01)

On the resistant pathogens problem of the recurrent vulvovaginal candidiasis
by: Yu V Dolgo-Saburova, et al.
Published: (2014-02-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)

Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
by: Zahra Vahedpoor, et al.
Published: (2021-09-01)

Modern opportunities for the diagnosis and treatment of vulvovaginal candidiasis (in aid of a practitioner)
by: E. R. Dovletkhanova, et al.
Published: (2019-10-01)

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01)

Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interrelationship
by: Jack D. Sobel, et al.
Published: (2024-01-01)

The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01)

Sweet Relief: Determining the Antimicrobial Activity of Medical Grade Honey Against Vaginal Isolates of <em>Candida albicans</em>
by: Renée Hermanns, et al.
Published: (2019-09-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis
by: T Yu Pestrikova, et al.
Published: (2014-06-01)

Comparison of the Efficacy of Honey Gel and Clotrimazole Cream in the Treatment of Vaginal Candidiasis Signs: A Randomized Clinical Trial
by: Zahra Seifinadergoli, et al.
Published: (2020-08-01)

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
by: Phillips NA, et al.
Published: (2023-02-01)

Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment
by: N. A. Buralkina, et al.
Published: (2019-08-01)

Clinical case: patient treated for vulvovaginal candidiasis
by: Tatyana Yu. Pestrikova
Published: (2021-02-01)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
by: Gai Ge, et al.
Published: (2022-07-01)

Use of antifungals in the treatment of vulvovaginal candidiasis: an integrative review
by: Kellyane Folha Gois Moreira, et al.
Published: (2023-12-01)

Zinc Plasma Levels in Recurrent Vulvovaginal Candidiasis Patients
by: Deryne Anggia Paramita, et al.
Published: (2017-04-01)

Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes
by: Lottie Brown, et al.
Published: (2022-08-01)

Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis
by: Margarita R. Rakhmatulina
Published: (2023-10-01)

Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management
by: Karolina Akinosoglou, et al.
Published: (2024-12-01)

Frequency and Etiology of Vulvovaginal Candidiasis in Women Referred to a Gynecological Center in Babol, lran
by: Seddigheh Esmaeilzadeh, et al.
Published: (2009-08-01)

Recent advances in vulvovaginal Candidiasis research: A narrative review
by: Debasmita Dubey, et al.
Published: (2023-11-01)

Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action
by: C.I.S. Medeiros, et al.
Published: (2022-08-01)

Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome
by: Changying Zhao, et al.
Published: (2023-06-01)

Epidemiological Profile of Patients with Vulvovaginal Candidiasis from a Sexually Transmitted Infection Clinic in Southern Spain
by: Encarnación Martínez-García, et al.
Published: (2023-05-01)

Intravaginal treatment features of vulvovaginal candidiasis in women
by: K Kurbanovna Mirzabalaeva, et al.
Published: (2013-12-01)

Natamycin in the treatment of chronic recurrent vulvovaginal candidiasis associated with intestinal candidiasis
by: I. O. Malova, et al.
Published: (2018-09-01)

ROLE OF GENOTYPING FEATURES IN THE DEVELOPMENT OF RECURRENT VULVOVAGINAL CANDIDIASIS AND THERAPY TACTICS
by: S. M. Pogosyan, et al.
Published: (2017-10-01)

The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis
by: Li L, et al.
Published: (2024-10-01)

Therapeutic approaches in the treatment of vulvovaginal candidiasis
by: A. Z. Khashukoeva, et al.
Published: (2020-10-01)

Evaluation of incidence and prevention of vulvovaginitis in juvenile stage: Professional article
by: Koledin Slađana, et al.
Published: (2016-01-01)

Chamomile Extract versus Clotrimazole Vaginal Cream in Treatment of Vulvovaginal Candidiasis: A Randomized Double-Blind Control Trial
by: Zahra Shiravani, et al.
Published: (2021-12-01)

Carbohydrate Derived Fulvic Acid for the Treatment of Vulvovaginal Candidiasis
by: Stewart Clark, et al.
Published: (2024-12-01)

Antifungal resistance profile in the treatment of vaginal candidiasis: A diagnosis of etiologic agents
by: Lisbeth Roxana Herreras Gomez, et al.
Published: (2022-04-01)

Effect of Honey Cinnamon Vaginal Cream and Clotrimazole Vaginal Cream on Improvement of Candida Vaginitis Symptoms in Women: Randomized Clinical Trial
by: Tayebeh Rasooli, et al.
Published: (2019-05-01)

Efficacy and safety of vaginal suppositories containing combination of Natamycin and Lactulose in treatment of vulvovaginal candidiasis: international, randomized, controlled, superiority clinical trial (combination of Natamycin and Lactulose for treatment of vulvovaginal candidiasis)
by: Oksana N. Volkova, et al.
Published: (2025-02-01)

Livarol in the treatment of chronic vulvovaginal candidiasis
by: Т. С. Дивакова, et al.
Published: (2017-06-01)